Recent advances in the treatment of acute lymphoblastic leukemia
H Rafei, HM Kantarjian, EJ Jabbour - Leukemia & lymphoma, 2019 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …
Recent advances in the treatment of acute lymphoblastic leukemia.
H Rafei, HM Kantarjian… - Leukemia & Lymphoma, 2019 - search.ebscohost.com
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …
Recent advances in the treatment of acute lymphoblastic leukemia
H Rafei, HM Kantarjian, EJ Jabbour - Leukemia & Lymphoma, 2019 - Taylor & Francis
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …
Recent advances in the treatment of acute lymphoblastic leukemia
H Rafei, HM Kantarjian… - Leukemia and …, 2019 - mdanderson.elsevierpure.com
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …
Recent advances in the treatment of acute lymphoblastic leukemia
H Rafei, HM Kantarjian… - Leukemia & …, 2019 - pubmed.ncbi.nlm.nih.gov
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …
Recent advances in the treatment of acute lymphoblastic leukemia.
H Rafei, HM Kantarjian, EJ Jabbour - Leukemia & Lymphoma, 2019 - europepmc.org
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution.
The progresses made in understanding its biology led to the development of targeted …
The progresses made in understanding its biology led to the development of targeted …